Preparation and characterization of dipyridamole solid dispersions for stabilization of supersaturation: effect of precipitation inhibitors type and molecular weight

References

• Zhou R, Moench P, Heran C, et al. pH-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of a canine model. Pharm Res 2005;22:188–192
   PubMed Web of Science ®Google Scholar
• Keserü GM, Makara GM. The influence of lead discovery strategies on the properties of drug candidates. Nat Rev Drug Dis 2009;8:203–212
   PubMed Web of Science ®Google Scholar
• Huanga LF, Tong WQ. Impact of solid state properties on developability assessment of drug candidates. Adv Drug Del Rev 2004;56:321–334
   PubMed Web of Science ®Google Scholar
• Hsieh YL, Ilevbare GA, Van Eerdenbrugh B, et al. pH-induced precipitation behavior of weakly basic compounds: determination of extent and duration of supersaturation using potentiometric titration and correlation to solid state properties. Pharm Res 2012;29:2738–2753
   PubMed Web of Science ®Google Scholar
• Xu L, Luo Y, Feng J, et al. Preparation and in vitro–in vivo evaluation of none gastric resident dipyridamole (DIP) sustained-release pellets with enhanced bioavailability. Int J Pharm 2012;422:9–16
   PubMed Web of Science ®Google Scholar
• Russell TL, Berardi RR, Barnett JL, et al. pH-related changes in the absorption of dipyridamole in the elderly. Pharm Res 1994;11:136–143
   PubMed Web of Science ®Google Scholar
• Terhaag B, Donath F, Le Petit G, Feller K. The absolute and relative bioavailability of dipyridamole from different preparations and the in vitro–in vivo comparison. Int J Clin Pharmacol Ther Toxicol 1986;24:298–302
   PubMed Web of Science ®Google Scholar
• Curatolo W, Nightingale JA, Herbig SM. Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu. Pharm Res 2009;26:1419–1431
   PubMed Web of Science ®Google Scholar
• Guzman HR, Tawa M, Zhang Z, et al. Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations. J Pharm Sci 2007;96:2686–2702
   PubMed Web of Science ®Google Scholar
• Warren DB, Benameur H, Porter CJ, Pouton CW. Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: a mechanistic basis for utility. J Drug Target 2010;18:704–731
   PubMed Web of Science ®Google Scholar
• Xu S, Dai WG. Drug precipitation inhibitors in supersaturable formulations. Int J Pharm 2013;453:36–43
   PubMed Web of Science ®Google Scholar
• Chauhan H, Hui-Gu C, Atef E. Correlating the behavior of polymers in solution as precipitation inhibitor to its amorphous stabilization ability in solid dispersions. J Pharm Sci 2013;102:1924–1935
   PubMed Web of Science ®Google Scholar
• Yamashita K, Nakate T, Okimoto K, et al. Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int J Pharm 2003;267:79–91
   PubMed Web of Science ®Google Scholar
• Won DH, Kim MS, Lee S, et al. Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process. Int J Pharm 2005;301:199–208
   PubMed Web of Science ®Google Scholar
• Han HK, Lee BJ, Lee HK. Enhanced dissolution and bioavailability of biochanin A via the preparation of solid dispersion: in vitro and in vivo evaluation. Int J Pharm 2011;415:89–94
   PubMed Web of Science ®Google Scholar
• Gao P, Guyton ME, Huang T, et al. Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturatable formulations. Drug Dev Ind Pharm 2004;30:221–229
   PubMed Web of Science ®Google Scholar
• Okimoto K, Miyake M, Ibuki R, et al. Dissolution mechanism and rate of solid dispersion particles of nilvadipine with hydroxypropylmethylcellulose. Int J Pharm 1997;159:85–93
   Web of Science ®Google Scholar
• Suzuki H, Sunada H. Influence of water-soluble polymers on the dissolution of nifedipine solid dispersions with combined carriers. Chem Pharm Bull 1998;46:482–487
   PubMed Web of Science ®Google Scholar
• Yokoi Y, Yonemochi E, Terada K. Effects of sugar ester and hydroxypropyl methylcellulose on the physicochemical stability of amorphous cefditoren pivoxil in aqueous suspension. Int J Pharm 2005;290:91–99
   PubMed Web of Science ®Google Scholar
• Pharmacopeia US. National Formulary. USP 30-NF 25. Rockville (MD): USP; 2006
   Google Scholar
• Moore JW, Flanner H. Mathematical comparison of dissolution profiles. Pharm Technol 1996;20:64–74
   Google Scholar
• Gohel MC, Panchal MK. Comparison of in vitro dissolution profiles using a novel, model-independent approach. Pharm Technol 2000;24:92–102
   Google Scholar
• Gohel MC, Panchal MK. Novel use of similarity factor f2 and Sd for the development of diltiazem HCl modified-release tablets using a 32 factorial design. Drug Dev Ind Pharm 2002;28:77–87
   PubMed Web of Science ®Google Scholar
• Rescigno A. Bioequivalence. Pharm Res 1992;9:925–928
   PubMed Web of Science ®Google Scholar
• Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123–133
   PubMed Web of Science ®Google Scholar
• Reppas C, Nicolaides E. Analysis of drug dissolution data. In: Dressman JB, Lennernäs H, eds. oral drug absorption prediction and assessment. New York: Marcel Dekker; 2000:229–254
   Google Scholar
• Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol 1975;27:48–49
   PubMed Web of Science ®Google Scholar
• Khan KA, Rhodes CT. Effect of compaction pressure on the dissolution efficiency of some direct compression systems. Pharm Act Helv 1972;47:594–607
   PubMedGoogle Scholar
• ICH Q1A(R2). 2003. Stability testing of new drug substances and products. Step 4 version, ICH harmonised tripartite guideline, ICH Expert Working Group. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1A_R2/Step4/Q1A_R2__Guideline.pdf [last accessed Oct 2014]
   Google Scholar
• Miller DA, DiNunzio JC, Yang W, et al. Enhanced in vivo absorption of itraconazole via stabilization of supersaturation following acidic-to-neutral pH transition. Drug Dev Ind Pharm 2008;34:890–902
   PubMed Web of Science ®Google Scholar
• Sahoo S, Chkraborti CK, Behera PK. Spectroscopic investigations of a ciprofloxacin/HPMC mucoadhesive suspension. Int J Appl Pharm 2012;4:1–8
   PubMedGoogle Scholar